Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

OS Fund

Investor type Venture Capital
Founders Bryan Johnson Jeff Klunzinger Jeffrey Klunzinger

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 46
Average round size
info
The average size of a deal this fund participated in
$21M
Portfolio companies 33
Rounds per year 5.75
Lead investments 6
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.28
Exits 5
Key employees 2

Areas of investment

  • Biotechnology
  • Health Care
  • Health Diagnostics
  • Genetics
  • Medical
Summary

This organization was formed by Bryan Johnson, Jeff Klunzinger, Jeffrey Klunzinger. We also calculated 4 valuable employees in our database.

The standard case for the fund is to invest in rounds with 6-7 partakers. Despite the OS Fund, startups are often financed by Founders Fund, Data Collective DCVC, Y Combinator. The meaningful sponsors for the fund in investment in the same round are Y Combinator, Founders Fund, Data Collective DCVC. In the next rounds fund is usually obtained by Y Combinator, Lux Capital, Data Collective DCVC.

Besides, a startup needs to be aged 4-5 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Therapeutics, Genetics. The fund has no exact preference in some founders of portfolio startups. When startup sums 5+ of the founder, the probability for it to get the investment is little. Among the most popular portfolio startups of the fund, we may highlight Cleversafe, Human Longevity, Ginkgo BioWorks.

The top amount of exits for fund were in 2018. The top activity for fund was in 2016. Despite it in 2019 the fund had an activity. Opposing the other organizations, this OS Fund works on 22 percentage points less the average amount of lead investments. Speaking about the real fund results, this VC is 3 percentage points less often commits exit comparing to other organizations. The usual things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in 7-12 investment rounds annually. The average startup value when the investment from OS Fund is 100-500 millions dollars.

Read more

Look at other 50 related and similar funds Collapse list
Fund NameLocation
China TBE Capital Partners Inc. -
Demosi Ziguan China, Guangdong, Tianjin
Dolma Impact Fund Ebène, Mauritius, Plaines Wilhems
F+ Ventures Istanbul, Istanbul, Turkey
Hillman Ventures Pennsylvania, Pittsburgh, United States
IXOLIT Austria, Vienna
KKR Real Estate Finance Trust New York, New York, United States
Nizar AlNusif Sons Holding -
NRJN Trust -
On Mauritius -
Pale Blue Dot Malmö, Skane Lan, Sweden
S-UBG Group Aachen, Germany, Nordrhein-Westfalen
SD Skytech -
Sidebench California, Santa Monica, United States
Soorim -
Stratus Technologies Massachusetts, Maynard, United States
Trinity Capital California, Los Angeles, United States
Vermillion Capital Minneapolis, Minnesota, United States
Zephyr Acorn Kenya, Nairobi, Nairobi Area

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Arzeda

Biotechnology
Information Services
Information Technology
$33M29 Mar 2022 Seattle, Washington, United States

Kenota Health

Biotechnology
Health Care
Health Diagnostics
Medical
$9M07 Dec 2020 Kitchener, Ontario, Canada

A-Alpha Bio

Biotechnology
Health Care
Product Design
$2M24 Sep 2019 Seattle, Washington, United States

GRO Biosciences

Biotechnology
Health Diagnostics
Medical Device
Pharmaceutical
Therapeutics
$3M13 Mar 2019 Boston, Massachusetts, United States

uBiome

Fitness
Genetics
Health Care
Wellness
$83M21 Sep 2018 San Francisco, California, United States

Lygos

Advanced Materials
Biotechnology
Clean Energy
$15M17 Jul 2018 Berkeley, California, United States

CATALOG

Biotechnology
Data Storage
Information Services
Information Technology
Software
$4M26 Jun 2018 Boston, Massachusetts, United States

NuMat Technologies

Hardware
Nanotechnology
Renewable Energy
Semiconductor
$12M26 Apr 2018 Illinois, United States

Aria Pharmaceuticals

Artificial Intelligence
Big Data
Biotechnology
Machine Learning
Pharmaceutical
$10M19 Mar 2018 Palo Alto, California, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent OS Fund?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: